Option Care Health, Inc. $OPCH Shares Sold by Villere ST Denis J & Co. LLC

Villere ST Denis J & Co. LLC lessened its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 1.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 866,519 shares of the company’s stock after selling 14,864 shares during the period. Option Care Health makes up approximately 2.3% of Villere ST Denis J & Co. LLC’s portfolio, making the stock its 22nd biggest holding. Villere ST Denis J & Co. LLC owned 0.53% of Option Care Health worth $24,055,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the business. Royal Bank of Canada grew its stake in shares of Option Care Health by 20.7% during the 1st quarter. Royal Bank of Canada now owns 231,161 shares of the company’s stock worth $8,078,000 after purchasing an additional 39,661 shares during the period. AQR Capital Management LLC boosted its holdings in Option Care Health by 162.6% during the first quarter. AQR Capital Management LLC now owns 41,633 shares of the company’s stock worth $1,450,000 after buying an additional 25,777 shares in the last quarter. Empowered Funds LLC acquired a new position in Option Care Health during the first quarter worth about $208,000. Blair William & Co. IL increased its holdings in Option Care Health by 67.9% in the second quarter. Blair William & Co. IL now owns 78,693 shares of the company’s stock valued at $2,556,000 after buying an additional 31,821 shares in the last quarter. Finally, Blue Trust Inc. increased its holdings in Option Care Health by 23.0% in the second quarter. Blue Trust Inc. now owns 6,495 shares of the company’s stock valued at $211,000 after buying an additional 1,213 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Wall Street Analyst Weigh In

OPCH has been the topic of a number of research reports. Wall Street Zen upgraded Option Care Health from a “hold” rating to a “buy” rating in a report on Saturday, January 10th. TD Cowen reiterated a “hold” rating on shares of Option Care Health in a research report on Tuesday, January 27th. Citigroup reissued an “outperform” rating on shares of Option Care Health in a report on Tuesday, January 13th. JMP Securities set a $36.00 price target on Option Care Health in a research note on Friday, October 31st. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Option Care Health in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, Option Care Health has an average rating of “Moderate Buy” and an average price target of $37.46.

Option Care Health Trading Up 1.8%

Option Care Health stock opened at $34.61 on Tuesday. The stock has a market cap of $5.49 billion, a PE ratio of 27.47, a P/E/G ratio of 2.03 and a beta of 0.80. The stock has a 50-day moving average price of $32.99 and a 200 day moving average price of $29.89. Option Care Health, Inc. has a 52 week low of $24.24 and a 52 week high of $36.80. The company has a current ratio of 1.56, a quick ratio of 1.05 and a debt-to-equity ratio of 0.85.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.